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Abstract SNAP-25 is a key protein required for the fusion of
synaptic vesicles with the plasma membrane during exocytosis.
This study establishes that SNAP-25 is di¡erentially phosphor-
ylated by protein kinase C and protein kinase A in neuroendo-
crine PC12 cells. Using phosphopeptide mapping and site-di-
rected mutagenesis we identi¢ed both Thr138 and Ser187 as
the targets of SNAP-25 phosphorylation by protein kinase C
and Thr138 as the exclusive site of SNAP-25 phosphorylation
by protein kinase A in vivo. Finally, despite published data to
the contrary, we demonstrate that stimulation of regulated exo-
cytosis under physiological conditions is independent of a mea-
surable increase in SNAP-25 phosphorylation in PC12 cells.
, 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Neurotransmitters and hormones are released from neuro-
nal cells by calcium-triggered exocytosis of secretory vesicles.
Extensive research on the molecular mechanisms underlying
exocytosis demonstrated that proteins termed SNAREs (solu-
ble NSF attachment protein (SNAP) receptors) are essential
mediators of synaptic vesicle fusion with the presynaptic plas-
ma membrane [1,2]. The membrane-associated SNARE com-
plex consists of interactions between SNAREs present on
vesicles (synaptobrevin family) and on target membranes (syn-
taxin and synaptosome-associated protein of 25 kDa (SNAP-
25) families [3]).
Protein phosphorylation represents an important mecha-
nism for regulating protein^protein interactions and numer-
ous studies have demonstrated its role in the control of neuro-
transmission [4]. While there have been studies showing that
the t-SNARE SNAP-25 can be phosphorylated [5^9], the
physiological relevance of SNARE phosphorylation remains
unclear. Although extreme conditions of neuronal stimulation
have been associated with SNAP-25 phosphorylation [8,9],
there are no data examining the importance of SNAP-25
phosphorylation under physiologically relevant conditions of
neurotransmitter release. In the present study we have bio-
chemically identi¢ed the sites of SNAP-25 phosphorylation
in neuroendocrine PC12 cells stimulated with phorbol 12-myr-
istate 13-acetate (PMA) or forskolin and have examined the
extent to which SNAP-25 phosphorylation correlates with
neurotransmitter release in vivo.
2. Materials and methods
2.1. Cell culture and transfections
PC12 cells (clone PC12G2, from Dr. Steven Sabol, National Heart,
Lung and Blood Institute, NIH, Bethesda, MD, USA) were grown in
Dulbecco’s modi¢ed Eagle’s medium (DMEM) containing 10% fetal
calf serum (HyClone Laboratories, Logan, UT, USA), 5% horse se-
rum (Sigma, St. Louis, MO, USA), 20 mM HEPES (pH 7.5) and 50
ng/ml gentamicin. Cells were maintained as subcon£uent monolayers
and passaged with 150 mM NaCl, 0.5 mM EDTA, 20 mM HEPES
(pH 7). HeLa cells were cultured and transiently transfected using
Lipofectamine (Gibco, Grand Island, NY, USA) as described previ-
ously [10].
2.2. Site-directed mutagenesis
SNAP-25 Ala mutants of Thr138, Ser187, and a Thr138/Ser187
double mutant were generated using the Quickchange mutagenesis
kit (Stratagene, La Jolla, CA, USA) with pcDNA3-SNAP-25b [11]
as template according to the manufacturer’s instructions. All muta-
tions were con¢rmed by automated sequence analysis using an ABI
sequencer.
2.3. Metabolic labeling of cells
HeLa and PC12 cells were plated at 1.5U106 and 3U106 cells per
10 cm dish respectively. Cells were starved the next day for 15 min in
phosphate-free DMEM containing 3% dialyzed calf serum (HyClone
Laboratories), 20 mM HEPES (pH 7.5), and gentamicin. Cells were
labeled with 0.5 mCi [32P]orthophosphate (NEN Life Science, Boston,
MA, USA) for 4 h in 1 ml phosphate-free DMEM. PC12 cells
were then stimulated for secretion as described below. PC12 and
transfected HeLa cells were also incubated with 1 WM ionomycin,
160 nM PMA or 40 WM forskolin for 30 min. Cells were washed
with ice-cold Hanks’ bu¡ered saline solution then frozen until further
use.
2.4. Immunoprecipitation and electrophoresis
Immunoprecipitation was carried out as described previously [10].
Brie£y, cells were lysed for 1 h in ice-cold lysis bu¡er containing 1%
Triton X-100 as well as protease and phosphatase inhibitors. Speci¢c
immunoprecipitation was performed for 2 h at 4‡C using the anti-
SNAP-25 monoclonal antibody (mAb) SMI81 (Sternberger Monoclon-
als, Lutherville, MD, USA). Proteins from the immunoprecipitates
were separated on a 12.5% SDS^PAGE and radiolabeled molecules
were visualized by autoradiography and the extent of phosphorylation
was quantitated by phosphorimager analysis. For tryptic digestion or
phosphoamino acid analysis, proteins were transferred to nitrocellu-
lose (0.2 Wm, Schleicher and Schuell, Keene, NH, USA) or polyvinyl-
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idene di£uoride (PVDF) (0.2 Wm; Bio-Rad, Hercules, CA, USA)
membranes which were exposed to a phosphorscreen overnight.
2.5. Phosphoamino acid analysis
Phosphoamino acid analysis was performed as described earlier [7].
SNAP-25 on the PVDF membrane was hydrolyzed in 6 N HCl for 2 h
at 110‡C. The hydrolysate was then vacuum dried and amino acids
resuspended in water. An aliquot and phosphoamino acid standards
were separated by thin layer chromatography (plates from E.M. Sci-
ence, Gibbstown, NJ, USA, No. 5577) with isobutyric acid:0.5 M
NH4OH (5:3 v/v). Standards were visualized with 0.2% ninhydrin
(Sigma) while [32P]amino acids were analyzed by autoradiography.
2.6. Tryptic digestion
Nitrocellulose pieces containing SNAP-25 were incubated 1 h at
37‡C in 1% PVP-40 (Sigma), washed twice with 0.4% NH4HCO3
(pH 8.0) and incubated overnight with 1 mg/ml trypsin at 37‡C in
the same bu¡er. The released peptides were dried in a speed-vac and
washed with H2O several times, then resuspended in 5^10 Wl H2O.
Aliquots were analyzed by autoradiography after thin layer chroma-
tography using butanol-1/pyridine/acetic acid/H2O (5:3:1:4 v/v).
2.7. [3H]Noradrenaline ([3H]NA) secretion
Secretion experiments from [3H]NA-loaded PC12 cells was per-
formed using 59 mM KCl or 60 WM nicotine in Locke solution [12]
or using 40 WM forskolin, 1 WM ionomycin, or 160 nM PMA in PC12
culture medium. Basal secretion was identical in each solution.
[3H]NA release was determined by measuring the radioactivity present
in the medium and in cells after precipitation with 10% trichloroacetic
acid. Release of [3H]NA is expressed as a percentage of total radio-
activity taken up by the cells.
2.8. Statistics
For quantitative experiments, statistical analyses were carried out
using the unpaired Student’s t-test. Results were considered signi¢cant
when a P value of less then 0.05 was obtained.
3. Results
3.1. Activation of protein kinase C (PKC) and
cAMP-dependent protein kinase (PKA) triggers
in vivo phosphorylation of SNAP-25
To address the role of SNAP-25 phosphorylation in vivo,
we set out to unambiguously identify the SNAP-25 phosphor-
ylation sites using phosphopeptide analysis and site-directed
mutagenesis. We metabolically labeled cells with
[32P]orthophosphate to examine the phosphorylation status
of endogenous SNAP-25 in rat pheochromocytoma PC12 cells
or SNAP-25-transfected HeLa cells (which normally do not
express SNAP-25). In untreated (control) cells, basal phos-
phorylation of SNAP-25 could be detected in each cell type
(Fig. 1A). Activation of PKC with PMA and PKA with for-
skolin increased the phosphorylation level of SNAP-25 in
both cell types. Phosphopeptide mapping of gel-puri¢ed and
trypsin-digested SNAP-25 showed that PMA treatment re-
sulted in the generation of two major tryptic phosphopeptides
(single and double asterisk), while forskolin induced the phos-
phorylation of only one fragment (single asterisk) in both
PC12 and HeLa cells (Fig. 1B). These data demonstrate that
the same tryptic fragments are phosphorylated in both cells
types, thereby allowing us to use expression of SNAP-25 point
mutants in HeLa cells to map the SNAP-25 phosphorylation
sites.
3.2. Identi¢cation of SNAP-25 phosphorylation sites in vivo
Phosphoamino acid analysis of untreated and PMA-stimu-
lated SNAP-25-transfected HeLa cells revealed that SNAP-25
is phosphorylated on both Ser and Thr residues (Fig. 2A). To
identify the PMA-induced as well as the forskolin-induced
phosphorylation sites, we generated Ala mutants of SNAP-
25 at positions Thr138 (an in vitro PKA site [7]), Ser187 (the
only described PKC site [5]), and a double Ala mutant of both
Ser187 and Thr138. These mutants were transfected into
HeLa cells, subsequently labeled with 32P, and stimulated
with PMA (Fig. 2B) or forskolin (Fig. 2C). Immunoblot anal-
ysis con¢rmed that all mutants were expressed at similar levels
(data not shown). As shown above, stimulation of PKC ac-
tivity with PMA gave rise to two prominent tryptic phospho-
peptides in wild-type SNAP-25. Replacement of Thr138 with
Ala resulted in the selective elimination of the upper spot,
demonstrating that this phosphopeptide contains phospho-
Thr138 only (Fig. 2B). Moreover, forskolin failed to stimulate
phosphorylation of the SNAP-25 Thr138Ala mutant in HeLa
cells (Fig. 2C), further demonstrating that Thr138 is phos-
phorylated by PKA in vivo. Replacement of Ser187 with
Ala resulted in the selective elimination of the lower spot,
indicating that this peptide contains phospho-Ser187. Com-
plete elimination of both PMA-induced tryptic phosphopep-
tides was only achieved in the Thr138/Ser187 double mutant,
demonstrating that both of these residues are phosphorylated
when cells are stimulated with PMA (Fig. 2B). Importantly, in
Fig. 1. SNAP-25 is phosphorylated in vivo. A: Basal and induced
SNAP-25 phosphorylation. PC12 cells (left panel) and SNAP-25-ex-
pressing HeLa cells (right panel) were loaded with 32P for 4 h prior
to stimulation for 30 min in medium alone (Control) or medium
containing either 160 nM PMA or 40 WM forskolin. SNAP-25 was
isolated by immunoprecipitation and analyzed by SDS^PAGE and
autoradiography. In the far left panel, immunoprecipitation from ly-
sates derived from untreated control cells was performed using ei-
ther isotype-matched irrelevant mAb (Mock IP) or SNAP-25 mAb
highlighting the speci¢city of the SNAP-25 mAb for immunoprecipi-
tation of [32P]SNAP-25. B: [32P]Phosphopeptide analysis. PC12 cells
(left panel) and SNAP-25-transfected HeLa cells (right panel) were
labeled with 32P for 4 h prior to stimulation for 30 min in medium
alone (Control) or medium containing either 160 nM PMA or 40
WM forskolin. SNAP-25 was isolated, subjected to trypsin digestion,
and analyzed by thin layer chromatography as described in the text.
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all mutants examined background labeling remained unaltered
(Fig. 2B,C), revealing further that Thr138 and Ser187 do not
contribute to basal SNAP-25 phosphorylation.
3.3. E¡ects of regulated secretion on SNAP-25 phosphorylation
Since SNAP-25’s major physiological function is related to
neurotransmitter secretion, we set out to determine if this
protein was inducibly phosphorylated by various secreta-
gogues in PC12 cells. Allowing calcium in£ux using ionomy-
cin, inducing membrane depolarization by KCl, and stimulat-
ing nicotinic acetylcholine receptors with nicotine all induced
robust neurotransmitter release, while forskolin or PMA
treatment alone failed to induce any secretion. In contrast,
co-treatment with PMA nearly doubled the amount of
[3H]NA released from ionomycin-stimulated cells (Fig. 3A).
In a parallel series of experiments, the phosphorylation sta-
tus of SNAP-25 was examined in 32P-loaded PC12 cells that
were stimulated for exocytosis. Treatment with forskolin in-
Fig. 2. Identi¢cation of SNAP-25 phosphorylation sites. A: Phos-
phoamino acid analysis. SNAP-25 from 32P-labeled transfected
HeLa cells treated with PMA was immunoprecipitated from cell ly-
sates, isolated by SDS^PAGE, subjected to total acid hydrolysis,
and phosphoamino acids were analyzed by thin layer chromatogra-
phy. Radiolabeled amino acids were visualized by autoradiography
and identi¢ed by comparison to phosphoamino acid standards
stained with ninhydrin. B,C: [32P]Phosphopeptide analysis of SNAP-
25 phosphorylation mutants. HeLa cells were transfected with the
pcDNA3 control vector (mock) or pcDNA3 containing wild-type,
Thr138Ala, Ser187Ala, Thr138Ala/Ser187Ala forms of SNAP-25.
After labeling with 32P cells were stimulated for 30 min with PMA
(B) or forskolin (C). SNAP-25 was isolated by immunoprecipitation
and tryptic phosphopeptides were analyzed as described in Fig. 1.
Fig. 3. Relationship between regulated secretion and SNAP-25 phos-
phorylation in PC12 cells. A: Secretion of PC12 cells in response to
various secretagogues. PC12 cells were loaded with [3H]NA for 2 h
before stimulation for 20 min with bu¡er alone (Control), forskolin,
ionomycin, PMA, ionomycin and PMA together, KCl, or nicotine.
Secretion was calculated as a percentage of [3H]NA released to the
total amount of cell-associated [3H]NA. *P6 0.05, ***P6 0.001 as
compared to the control sample. B: SNAP-25 phosphorylation in
response to various secretagogues. PC12 cells were loaded with 32P
for 4 h and stimulated for 20 min with each of the secretagogues
listed above. Each treatment was performed in triplicate. The cells
were lysed and immunoprecipitations with isotype-matched irrele-
vant mAb (Mock IP, ¢rst lane) or anti-SNAP-25 mAb (all other
lanes) were performed. The immunoprecipitates were analyzed by
SDS^PAGE and autoradiography. C: Quantitation of SNAP-25
phosphorylation. The amount of [32P]SNAP-25 present in each con-
dition shown in B was quantitated by phosphorimager analysis. The
data are shown as the averageTS.D. for the triplicate samples.
*P6 0.05, ***P6 0.001 as compared to the control sample.
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creased SNAP-25 phosphorylation two-fold while PMA
(alone or together with ionomycin) increased SNAP-25 phos-
phorylation four-fold (Fig. 3B,C). Most importantly, despite
their stimulation of exocytosis, neither KCl, nicotine, nor ion-
omycin alone induced any measurable change in SNAP-25
phosphorylation.
Since these data were obtained 20 min after secretagogue
administration, we explored the possibility that a transient
‘burst’ of phosphorylation occurred either prior to or subse-
quent to this time point. While we observed the expected time-
dependent increase in neurotransmitter release from KCl-
stimulated cells (up to V50% release at 1 h, Fig. 4A), we
did not detect any appreciable changes in SNAP-25 phosphor-
ylation when assayed over the period of 60 min (Fig. 4B,C),
demonstrating that e⁄cient neurotransmitter release is inde-
pendent of a measurable increase in SNAP-25 phosphoryla-
tion.
4. Discussion
Although Ser187 has been described as the unique target of
PKC phosphorylation on SNAP-25 [5], we now have identi-
¢ed Thr138 as an additional PKC phosphorylation site of
endogenous SNAP-25 in PC12 cells. Moreover, our identi¢-
cation of Thr138 as the exclusive in vivo target of PKA phos-
phorylation on SNAP-25 is in excellent agreement with in
vitro data showing that this residue is phosphorylated by
PKA [7]. Despite a previous report suggesting that induction
of neurotransmitter release leads to SNAP-25 phosphoryla-
tion [5], we found no correlation between the ability of vari-
ous secretagogues to induce vesicle exocytosis and their ability
to induce SNAP-25 phosphorylation in PC12 cells. Indeed,
PMA or forskolin treatment alone resulted in dramatic phos-
phorylation of SNAP-25 Ser187 and/or Thr138 without ap-
preciable neurotransmitter release, while membrane depolar-
ization using KCl or nicotine caused robust neurotransmitter
release but had no detectable e¡ect on SNAP-25 phosphory-
lation. We conclude therefore that the increase in SNAP-25
phosphorylation observed previously was a consequence of
directly stimulating PKC by PMA and that physiological
stimulation of neurotransmitter release from PC12 cells is
not accompanied by dramatic changes in SNAP-25 phosphor-
ylation.
During the preparation of this article Gonelle-Gispert et al.
[13] reported that insulin secretion from pancreatic L-cells was
also independent of SNAP-25 phosphorylation. This ¢nding is
consistent with our data showing a lack of correlation of
SNAP-25 phosphorylation and exocytosis as well as studies
showing that overexpression of the SNAP-25 Thr138/Ser187
double mutant did not interfere with KCl-induced exocytosis
from PC12 cells (R. Hepp and P.A. Roche, data not shown).
Together these data argue against an important role of
SNAP-25 phosphorylation during the process of regulated
exocytosis.
These data, along with those in the recent literature con-
cerning Ser187 phosphorylation [14,15], show that massive
SNAP-25 phosphorylation is not a prerequisite for e⁄cient
neurotransmitter release from PC12 cells. However, addition
of nerve growth factor to PC12 cells can indeed lead to tran-
sient SNAP-25 phosphorylation over a period of days [9],
although this process of di¡erentiation is dependent upon
cellular signaling and not necessarily exocytosis. Moreover,
induction of long-term potentiation or epileptic-like seizures
using bicuculline increases SNAP-25 phosphorylation in rat
hippocampal slices [8]. In the case of long-term potentiation,
increase of the postsynaptic response occurs after a tetanic
stimulation of presynaptic neurons, while during drug-induced
seizures hyperactivity and synchronization develop within the
hippocampus neuronal network [16,17]. Thus, it is conceivable
that sustained neuronal activity leads to kinase activation and
SNAP-25 phosphorylation. The unambiguous identi¢cation of
SNAP-25 Thr138 and Ser187 as targets for PKC and Thr138
as the target for PKA in vivo described in this study provides
Fig. 4. Kinetics of regulated secretion and SNAP-25 phosphoryla-
tion in PC12 cells. A: Time course of regulated secretion. PC12 cells
were loaded with [3H]NA and exocytosis triggered with 59 mM
KCl. Supernatants were harvested at various times and the cells
were lysed. Secretion was calculated as a percentage of radioactivity
present in the supernatant relative to the total amount of [3H]NA
taken up by the cells. B,C: SNAP-25 phosphorylation during PC12
cell secretion. PC12 cells were loaded with 32P for 4 h prior to stim-
ulation with KCl. At various times the cells were washed extensively
in ice-cold bu¡er, lysed, and the amount of [32P]SNAP-25 present in
the cells was determined by immunoprecipitation, SDS^PAGE, and
quantitative phosphorimager analysis.
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the foundation for further studies aimed to clarify the role of
phosphorylation for SNAP-25 function.
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